Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 2:42 PM
Ignite Modification Date:
2025-12-24 @ 2:42 PM
NCT ID:
NCT02269059
Eligibility Criteria:
Inclusion Criteria:
* Is in good health except for HCV infection
* Is male or is a female of non-childbearing potential
* Clinical diagnosis of HCV GT1 or GT3 with no evidence of mixed-GT or non-typeable infection
Exclusion Criteria:
* Has a history of clinically significant and not stably controlled endocrine, gastrointestinal, cardiovascular, hematological, hepatic (excepting HCV infection), immunological, renal, respiratory, genitourinary, or major neurological abnormality or disease
* Has a history of cancer
* Has a history of significant multiple and/or severe allergies
* Is positive for hepatitis B or human immunodeficiency virus
* Has had major surgery, donated or lost 1 unit (500 mL) of blood within 4 weeks prior to screening
* Consumes more than 2 alcoholic beverages per day or is currently a regular user of any illicit drug(s) or has a history of alcohol/drug abuse within 12 months prior to screening
* Has chronic hepatitis not caused by HCV (e.g., nonalcoholic steatohepatitis \[NASH\])
* Has clinical or laboratory evidence of advanced or decompensated liver disease, or evidence of bridging or higher grade fibrosis
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
65 Years
Study:
NCT02269059
Study Brief:
Protocol Section:
NCT02269059